Clinical trial NCT02681848 - References

Depression — What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?

Citation(s)

•   Action on Smoking and Health, Smoking statistics who smokes and how much (2014), (available at http://www
  ash.org.uk/files/documents/ASH_106.pdf).
•   Allender S, Balakrishnan R, Scarborough P, Webster P, Rayner M
  The burden of smoking-related ill health in the UK. Tob Control. 2009 Aug;18(4):262-7. doi: 10.1136/tc.2008.026294. Epub 2009 Jun 9. Review.
•   B
  R. Kirkwood, J. A. . Sterne, Essential medical statistics (Wiley-Blackwell, 2003).
•   Booth HP, Prevost AT, Gulliford MC
  Validity of smoking prevalence estimates from primary care electronic health records compared with national population survey data for England, 2007 to 2011. Pharmacoepidemiol Drug Saf. 2013 Dec;22(12):1357-61.
•   Brookhart MA, Wang PS, Solomon DH, Schneeweiss S
  Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology. 2006 May;17(3):268-75.
•   Brown T, Platt S, Amos A
  Equity impact of European individual-level smoking cessation interventions to reduce smoking in adults: a systematic review. Eur J Public Health. 2014 Aug;24(4):551-6. doi: 10.1093/eurpub/cku065. Epub 2014 Jun 1. Review.
•   C
  Baum, M. Schaffer, S. Stillman, IVREG2: Stata module for extended instrumental variables/2SLS and GMM estimation. Stat. Softw. Compon. (2002).
•   Cahill K, Stevens S, Perera R, Lancaster T
  Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013 May 31;(5):CD009329. doi: 10.1002/14651858.CD009329.pub2. Review.
•   Charlson ME, Pompei P, Ales KL, MacKenzie CR
  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
•   Clarke PS, Windmeijer F
  Identification of causal effects on binary outcomes using structural mean models. Biostatistics. 2010 Oct;11(4):756-70. doi: 10.1093/biostatistics/kxq024. Epub 2010 Jun 3.
•   Cole SR, Platt RW, Schisterman EF, Chu H, Westreich D, Richardson D, Poole C
  Illustrating bias due to conditioning on a collider. Int J Epidemiol. 2010 Apr;39(2):417-20. doi: 10.1093/ije/dyp334. Epub 2009 Nov 19.
•   D
  of Health, Smoking kills: a White Paper on tobacco (1998), (available at http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4006684).
•   Davies NM, Gunnell D, Thomas KH, Metcalfe C, Windmeijer F, Martin RM
  Physicians' prescribing preferences were a potential instrument for patients' actual prescriptions of antidepressants. J Clin Epidemiol. 2013 Dec;66(12):1386-96. doi: 10.1016/j.jclinepi.2013.06.008. Epub 2013 Sep 24.
•   Davies NM, Smith GD, Windmeijer F, Martin RM
  COX-2 selective nonsteroidal anti-inflammatory drugs and risk of gastrointestinal tract complications and myocardial infarction: an instrumental variable analysis. Epidemiology. 2013 May;24(3):352-62. doi: 10.1097/EDE.0b013e318289e024.
•   Douglas L, Szatkowski L
  Socioeconomic variations in access to smoking cessation interventions in UK primary care: insights using the Mosaic classification in a large dataset of primary care records. BMC Public Health. 2013 Jun 5;13:546. doi: 10.1186/1471-2458-13-546.
•   Drug Safety and Availability > FDA Drug Safety Communication: Safety review update of Chantix (varenicline) and risk of neuropsychiatric adverse events, (available at http://www
  fda.gov/Drugs/DrugSafety/ucm276737.htm).
•   E
  Leuven, B. Sianesi, PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. Stat. Softw. Compon. (2012) (available at http://ideas.repec.org/c/boc/bocode/s432001.html).
•   Glynn RJ, Schneeweiss S, Stürmer T
  Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):253-9. Review.
•   Hernán MA, Alonso A, Logan R, Grodstein F, Michels KB, Willett WC, Manson JE, Robins JM
  Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology. 2008 Nov;19(6):766-79. doi: 10.1097/EDE.0b013e3181875e61.
•   Hernán MA, Robins JM
  Instruments for causal inference: an epidemiologist's dream? Epidemiology. 2006 Jul;17(4):360-72. Erratum in: Epidemiology. 2014 Jan;25(1):164.
•   Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ
  Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010 Jan;69(1):4-14. doi: 10.1111/j.1365-2125.2009.03537.x. Review.
•   Hiscock R, Bauld L, Amos A, Fidler JA, Munafò M
  Socioeconomic status and smoking: a review. Ann N Y Acad Sci. 2012 Feb;1248:107-23. doi: 10.1111/j.1749-6632.2011.06202.x. Epub 2011 Nov 17. Review.
•   J
  D. Angrist, G. W. Imbens, D. B. Rubin, Identification of causal effects using instrumental variables. J. Am. Stat. Assoc.. 91, 444-455 (1996).
•   Jha P, Peto R
  Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med. 2014 Jan 2;370(1):60-8. doi: 10.1056/NEJMra1308383.
•   Joffe MM
  Confounding by indication: the case of calcium channel blockers. Pharmacoepidemiol Drug Saf. 2000 Jan;9(1):37-41. doi: 10.1002/(SICI)1099-1557(200001/02)9:1<37::AID-PDS471>3.0.CO;2-U.
•   Khan NF, Perera R, Harper S, Rose PW
  Adaptation and validation of the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract. 2010 Jan 5;11:1. doi: 10.1186/1471-2296-11-1.
•   Kotz D, West R
  Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding. Tob Control. 2009 Feb;18(1):43-6. doi: 10.1136/tc.2008.025981. Epub 2008 Oct 20.
•   L
  Hansen, K. Singleton, Generalized instrumental variables estimation of nonlinear rational expectations models. Econometrica. 50, 1269-1286 (1982).
•   Langley TE, Szatkowski L, Gibson J, Huang Y, McNeill A, Coleman T, Lewis S
  Validation of The Health Improvement Network (THIN) primary care database for monitoring prescriptions for smoking cessation medications. Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):586-90. doi: 10.1002/pds.1960.
•   Marston L, Carpenter JR, Walters KR, Morris RW, Nazareth I, White IR, Petersen I
  Smoker, ex-smoker or non-smoker? The validity of routinely recorded smoking status in UK primary care: a cross-sectional study. BMJ Open. 2014 Apr 23;4(4):e004958. doi: 10.1136/bmjopen-2014-004958.
•   McMahon AD
  Approaches to combat with confounding by indication in observational studies of intended drug effects. Pharmacoepidemiol Drug Saf. 2003 Oct-Nov;12(7):551-8.
•   Office of National Statistics, Do smoking rates vary between more and less advantaged areas? (2014), (available at http://www
  ons.gov.uk/ons/rel/disability-and-health-measurement/do-smoking-rates-vary-between-more-and-less-advantaged-areas-/2012/sty-smoking-rates.html).
•   P
  R. Rosenbaum, D. B. Rubin, Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score. Am. Stat.. 39, 33 (1985).
•   P
  R. Rosenbaum, D. B. Rubin, The Central Role of the Propensity Score in Observational Studies for Causal Effects. Biometrika. 70, 41 (1983).
•   P
  S. Clarke, F. Windmeijer, Instrumental Variable Estimators for Binary Outcomes. J. Am. Stat. Assoc.. 107, 1638-1652 (2012).
•   Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R
  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000 Aug 5;321(7257):323-9.
•   Quint JK, Müllerova H, DiSantostefano RL, Forbes H, Eaton S, Hurst JR, Davis K, Smeeth L
  Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD). BMJ Open. 2014 Jul 23;4(7):e005540. doi: 10.1136/bmjopen-2014-005540.
•   Ratschen E, Britton J, McNeill A
  The smoking culture in psychiatry: time for change. Br J Psychiatry. 2011 Jan;198(1):6-7. doi: 10.1192/bjp.bp.110.081372.
•   Stata Statistical Software: Release 13
  (College Station, TX: StataCorp LP, 2013).
•   The Pharmacovigilance Expert Advisory Group, Summary report based on the minutes of the Pharmacovigilance Expert Advisory Group meeting held on Wednesday 3 July 2013 (2013), (available at http://www
  mhra.gov.uk/home/groups/l-cs-el/documents/committeedocument/con322356.pdf).
•   Thomas KH, Martin RM, Davies NM, Metcalfe C, Windmeijer F, Gunnell D
  Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study. BMJ. 2013 Oct 11;347:f5704. doi: 10.1136/bmj.f5704.
•   Van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HG
  The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf. 2000 Sep;9(5):359-66. doi: 10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E.

Details for clinical trial NCT02681848